Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.80SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CK.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.5.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.37.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.77SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.52SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.65SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.75SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.18.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
GL.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.5.78SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EG.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CR.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FL.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBKSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.14.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DF.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used